Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.

2.50
Hdl Handle:
http://hdl.handle.net/11287/619938
Title:
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Authors:
Jones-Hughes, T; Snowsill, T.; Haasova, Marcela; Coelho, H; Crathorne, L.; Cooper, C; Mujica-Mota, R; Peters, J; Varley-Campbell, J.; Huxley, N.; Moore, J.; Allwood, M.; Lowe, J.; Hyde, C. J.; Hoyle, M.; Bond, M.; Anderson, R.
Abstract:
End-stage renal disease is a long-term irreversible decline in kidney function requiring renal replacement therapy: kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney transplantation, followed by immunosuppressive therapy (induction and maintenance therapy) to reduce the risk of kidney rejection and prolong graft survival.
Citation:
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. 2016, 20 (62):1-594 Health Technol Assess
Publisher:
NIHR
Journal:
Health Technology Assessment
Issue Date:
Aug-2016
URI:
http://hdl.handle.net/11287/619938
DOI:
10.3310/hta20620
PubMed ID:
27578428
Additional Links:
http://dx.doi.org/10.3310/hta20620
Note:
This article is freely available. Click on the 'Additional Link' above to access the full-text.
Type:
Meta-Analysis
Language:
en
ISSN:
2046-4924
Appears in Collections:
Exeter Kidney Unit (Renal); 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorJones-Hughes, Ten
dc.contributor.authorSnowsill, T.en
dc.contributor.authorHaasova, Marcelaen
dc.contributor.authorCoelho, Hen
dc.contributor.authorCrathorne, L.en
dc.contributor.authorCooper, Cen
dc.contributor.authorMujica-Mota, Ren
dc.contributor.authorPeters, Jen
dc.contributor.authorVarley-Campbell, J.en
dc.contributor.authorHuxley, N.en
dc.contributor.authorMoore, J.en
dc.contributor.authorAllwood, M.en
dc.contributor.authorLowe, J.en
dc.contributor.authorHyde, C. J.en
dc.contributor.authorHoyle, M.en
dc.contributor.authorBond, M.en
dc.contributor.authorAnderson, R.en
dc.date.accessioned2016-09-07T09:22:32Z-
dc.date.available2016-09-07T09:22:32Z-
dc.date.issued2016-08-
dc.identifier.citationImmunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. 2016, 20 (62):1-594 Health Technol Assessen
dc.identifier.issn2046-4924-
dc.identifier.pmid27578428-
dc.identifier.doi10.3310/hta20620-
dc.identifier.urihttp://hdl.handle.net/11287/619938-
dc.description.abstractEnd-stage renal disease is a long-term irreversible decline in kidney function requiring renal replacement therapy: kidney transplantation, haemodialysis or peritoneal dialysis. The preferred option is kidney transplantation, followed by immunosuppressive therapy (induction and maintenance therapy) to reduce the risk of kidney rejection and prolong graft survival.en
dc.language.isoenen
dc.publisherNIHRen
dc.relation.urlhttp://dx.doi.org/10.3310/hta20620en
dc.rightsArchived with thanks to Health technology assessment (Winchester, England)en
dc.subjectWessex Classification Subject Headings::Urology::Nephrology/Renal medicineen
dc.titleImmunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.en
dc.typeMeta-Analysisen
dc.identifier.journalHealth Technology Assessmenten
dc.description.noteThis article is freely available. Click on the 'Additional Link' above to access the full-text.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.